Stand Up to Cancer Launches $7.5 Million Research Program

Stand Up to Cancer and the American Association for Cancer Research have announced the launch of a $7.5 million grants program aimed at supporting early-career scientists pursuing innovative research focused on immuno-oncology.

Funded by the Bristol-Myers Squibb Company, the Innovative Research Grants program will award ten three-year grants of up to $750,000 each in support of novel, high-risk, high-reward cancer immunology research projects that have significant potential for translation to clinical application. The deadline for proposals is January 12, 2017.

"Immuno-oncology is an exciting field in research today," said William G. Kaelin, Jr., professor of medicine and associate director of basic science at the Dana-Farber Cancer Institute and Harvard Medical School and chair of the SU2C Innovative Research Grant Committee. "It has yielded a number of revolutionary new approaches to cancer treatment, and we are eager to find and support scientists early in their careers who can help move the field even further forward."

"Research Grants Focusing on Immuno-Oncology, Supported by a Grant From Bristol-Myers Squibb." American Association for Cancer Research Press Release 11/10/2016.
Subjects: health; medical research
People: william g. kaelin, jr.
Organization: american association for cancer research; bristol-myers squibb; stand up to cancer
Location: national